Epsium Reports $3.04M Revenue in First Half 2025 Post-IPO
- Financial Overview: Epsium reported revenue of $3.04 million in the first half of 2025, a significant drop from $7.11 million in the same period of 2024, primarily reflecting challenges related to customer order timing and inventory optimization strategies, indicating market demand volatility.
- Profitability Analysis: The company achieved a gross profit of $0.50 million with a gross margin of 16.28%, an improvement from 13.09% a year ago, demonstrating that a higher mix of premium products has enhanced profitability despite the overall revenue decline.
- Liquidity Position: As of June 30, 2025, Epsium's cash and cash equivalents stood at $2.43 million, the highest level since 2023, reflecting effective capital deployment strategies post-IPO that have strengthened the company's liquidity.
- Shareholder Structure Adjustment: In August 2025, shareholders approved the introduction of a multi-class share structure, further enhancing corporate governance standards in line with international capital market practices, which may attract more investor interest.
Trade with 70% Backtested Accuracy
Analyst Views on EPSM
About EPSM
About the author

- Board Composition Change: Epsium Enterprise Limited announced a change in its Board of Directors, with Kewei Joshua Cui resigning from all positions effective March 31, 2026, for personal reasons, indicating stability in corporate governance without management disagreements.
- New Independent Director: Chun Kit Wong has been appointed as an independent director and committee member effective April 1, 2026, meeting Nasdaq's independence requirements, and is expected to leverage his extensive finance and corporate management experience to support the company's future growth.
- Compensation Agreement: Under the Independent Director Agreement, Wong will receive an annual compensation of $20,000, payable monthly, aimed at attracting high-caliber independent directors to enhance corporate governance standards.
- Company Overview: Epsium, through its Macau subsidiary Luz, engages in the import and wholesale of alcoholic beverages, particularly high-end Chinese liquor, solidifying its leading position in the Macau market while continuing to monitor market dynamics for strategic business optimization.
- Board Composition Change: Epsium Enterprise Limited announced a change in its Board of Directors, with Kewei Joshua Cui resigning from all positions effective March 31, 2026, for personal reasons, indicating stability in corporate governance without management disputes.
- New Independent Director: Chun Kit Wong will join the Board as an independent director and member of several committees effective April 1, 2026, meeting Nasdaq's independence requirements, which is expected to enhance the Board's expertise with his extensive finance and management experience.
- Compensation Agreement: Wong's Independent Director Agreement stipulates an annual compensation of $20,000, payable monthly, aimed at attracting high-quality independent directors to improve corporate governance standards.
- Background and Experience: Wong brings significant financial and corporate management experience from various financial institutions, and his expertise is anticipated to aid the company in making informed decisions in a complex market environment.
- Innovative Tool Launch: EPSMomentum has introduced its AI Analyst tool designed to streamline stock selection by rapidly analyzing the latest company releases, earnings call transcripts, and CEO commentary, thereby enhancing the accuracy and efficiency of investment decisions.
- Data-Driven Insights: The tool summarizes key financial performance, growth rates, and competitive analysis on a single platform, enabling investors to quickly access critical information and alleviate the overwhelm of information overload, which boosts their confidence in decision-making.
- Industry Recognition: EPSMomentum was awarded the Best Financial Research App at the 2025 Benzinga FinTech Awards for its innovative technology, highlighting its leadership in the financial research space and further enhancing its brand influence.
- Personalized Investment Support: The AI Analyst tool not only provides personalized analysis and continuous monitoring but also sets a new standard for transparency and accessibility in financial research by combining AI-driven insights with original source documents, empowering investors to make data-driven decisions.
- Financial Overview: Epsium reported revenue of $3.04 million in the first half of 2025, a significant drop from $7.11 million in the same period of 2024, primarily reflecting challenges related to customer order timing and inventory optimization strategies, indicating market demand volatility.
- Profitability Analysis: The company achieved a gross profit of $0.50 million with a gross margin of 16.28%, an improvement from 13.09% a year ago, demonstrating that a higher mix of premium products has enhanced profitability despite the overall revenue decline.
- Liquidity Position: As of June 30, 2025, Epsium's cash and cash equivalents stood at $2.43 million, the highest level since 2023, reflecting effective capital deployment strategies post-IPO that have strengthened the company's liquidity.
- Shareholder Structure Adjustment: In August 2025, shareholders approved the introduction of a multi-class share structure, further enhancing corporate governance standards in line with international capital market practices, which may attract more investor interest.

LexinFintech Holdings Performance: LexinFintech Holdings Ltd reported a significant increase in quarterly earnings, rising to 43 cents per share from 28 cents a year ago, despite a drop in sales to $367.580 million from $521.851 million. The stock surged 15.3% in pre-market trading.
Other Gainers in Pre-Market Trading: Several stocks saw notable increases in pre-market trading, including Inspire Veterinary Partners Inc (+54.4%), VisionSys AI Inc (+43.4%), and JX Luxventure Group Inc (+36.2%).
Losers in Pre-Market Trading: Conversely, stocks like Clearside Biomedical Inc (-50.3%), Shuttle Pharmaceuticals Holdings Inc (-15%), and XChange TEC.INC (-14%) experienced significant declines in pre-market trading.
Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting both gainers and losers, along with specific percentage changes.

U.S. Stock Market Trends: U.S. stock futures are down, with the Dow futures dropping over 100 points, indicating a bearish market sentiment.
Notable Stock Movements: Energy Fuels Inc. shares fell 6.4% after announcing a $550 million private offering, while other companies like Epsium Enterprise Limited and JFB Construction Holdings also experienced significant pre-market declines.








